CDH1 and renal pelvis/ureter urothelial carcinoma: To the best of our knowledge, our study is the first systematic review and meta-analysis to evaluate the prognostic value of E-cadherin expression with a focus on survival benefits in patients with UTUC, which may help clinicians plan subsequent treatments after radical surgery.